Characterization of a zebrafish model of MYC-driven acute myeloid leukemia

被引：0
|
作者：
Luciano, A. M. [1 ]
Rodriguez-Vidal, J. F. [1 ]
Fernandez-Lajarin, M. [2 ,3 ]
Cayuela-Fuentes, M. L. [2 ,3 ]
Garcia-Moreno, D. [2 ,3 ]
Mulero-Mendez, V. [1 ]
机构：
[1] Univ Murcia, Dept Celular Biol & Histol, Murcia, Spain
[2] Hosp Clin Univ Virgen Arrixaca, IMIB Arrixaca, Murcia, Spain
[3] IMIB Arrixaca, Murcia, Spain
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.714
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
851P
引用
收藏
页码：S552 / S552
页数：1
相关论文
共 50 条
  • [41] MYC-driven synthesis of Siglec ligands is a glycoimmune checkpoint
    Smith, Benjamin A. H.
    Deutzmann, Anja
    Correa, Kristina M.
    Delaveris, Corleone S.
    Dhanasekaran, Renumathy
    Dove, Christopher G.
    Sullivan, Delaney K.
    Wisnovsky, Simon
    Stark, Jessica C.
    V. Pluvinage, John
    Swaminathan, Srividya
    Riley, Nicholas M.
    Rajan, Anand
    Majeti, Ravindra
    Felsher, Dean W.
    Bertozzi, Carolyn R.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2023, 120 (11)
  • [42] The role of PRMT5 in MYC-driven medulloblastoma
    Chaturvedi, Nagendra K.
    Kesherwani, Varun
    Kling, Matthew J.
    Ray, Sutapa
    McGuire, Timothy R.
    Joshi, Shantaram S.
    Sharp, J. Graham
    Coulter, Don W.
    CANCER RESEARCH, 2019, 79 (13)
  • [43] FoxO3 suppresses Myc-driven lymphomagenesis
    C J Vandenberg
    N Motoyama
    S Cory
    Cell Death & Disease, 2016, 7 : e2046 - e2046
  • [44] TARGETING APOPTOSIS AS A NOVEL THERAPY FOR MYC-DRIVEN MEDULLOBLASTOMA
    Ji, Pengxiang
    Genovesi, Laura
    He, Yaowu
    Hooper, John
    Wainwright, Brandon
    NEURO-ONCOLOGY, 2016, 18 : 110 - 110
  • [45] IDENTIFICATION OF NOVEL THERAPEUTIC APPROACHES FOR MYC-DRIVEN MEDULLOBLASTOMA
    Taban, Kuebra
    Pauck, David
    Maue, Mara
    Marquardt, Viktoria
    Yu, Hua
    Ayrault, Olivier
    Picard, Daniel
    Bartl, Jasmin
    Qin, Nan
    Borkhardt, Arndt
    Reifenberger, Guido
    Remke, Marc
    NEURO-ONCOLOGY, 2020, 22 : 406 - 406
  • [46] MYC-Driven SCLC Has Unique Metabolic Vulnerabilities
    Wait, S. J.
    Chalishazar, M. D.
    Huang, F.
    Bomalaski, J. S.
    DeBerardinis, R. J.
    Oliver, T. G.
    JOURNAL OF THORACIC ONCOLOGY, 2020, 15 (02) : S14 - S14
  • [47] The spliceosome, a potential Achilles heel of MYC-driven tumors
    Olga Anczuków
    Adrian R. Krainer
    Genome Medicine, 7
  • [48] INTERROGATING THE ROLE OF EPIGENETIC REGULATORS IN MYC-DRIVEN MEDULLOBLASTOMA
    Stripay, Jennifer
    Morfouace, Marie
    Vakoc, Christopher
    Roussel, Martine
    NEURO-ONCOLOGY, 2019, 21 : 108 - 108
  • [49] Spotlight on New Therapeutic Opportunities for MYC-Driven Cancers
    D'Avola, Annalisa
    Kluckova, Katarina
    Finch, Andrew J.
    Riches, John C.
    ONCOTARGETS AND THERAPY, 2023, 16 : 371 - 383
  • [50] Scribble acts as an oncogene in Eμ-myc-driven lymphoma
    Hawkins, E. D.
    Oliaro, J.
    Ramsbottom, K. M.
    Newbold, A.
    Humbert, P. O.
    Johnstone, R. W.
    Russell, S. M.
    ONCOGENE, 2016, 35 (09) : 1193 - 1197
12345